FDA Inspection 1078259 — Lubos Janu, MD

Lubos Janu, MD — FEI 3014808809

The FDA completed an inspection of Lubos Janu, MD on Dec 14, 2018 in Plzen 12. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 14, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plzen 12 (Czech Republic)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.